Connect with us

Hi, what are you looking for?

Jewish Business News

Search results for "Copaxone"

Court

...s a year because it knew they would use the money to cover the payments to Copaxone, thus increasing Copaxone sales and enriching Teva...

Life science

...ed on the assessment that there will be additional generic competition for Copaxone as of April 2018. Teva’s working assumption was that Copaxone sales...

Court

...y in favor of Mylan and its Dutch partner Synthon, and canceled all Teva’s Copaxone for 40 mg in the country based on obviousness....

Business

...specialty medicines available to Japanese patients.” Japanese approval for Copaxone is based on the safety and efficacy results of an open-label, 52-week clinical trial...

Business

...ded litigation has benefited Teva, which has been able to continue to sell Copaxone without competition from other manufacturers that would offer steep discounts...

Business

...he looming loss of significant revenue from the end of exclusivity for the Copaxone® franchise, and has seen years of consistent and significant underperformance,...

Business

...omberg. “This is a good deal for Teva. It will add to its product line in the central nervous system space and shows that...

Business

.... 15 months of exclusive branded sales is worth a great deal to Teva, with Copaxone recording annual sales of $4 billion. Sandoz, Mylan,...

Business

...round half of the group’s profit is derived from a single branded product, Copaxone. Copaxone will likely face generic competition in 2015 in its...

Court

...to explore all available avenues to protect our intellectual property for Copaxone 20mg/mL. Copaxone will remain a proprietary, global market leading product for the...

More Posts
cialis cialis satış